Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions

Annals of Neurology

Volumn 70, Issue 1, 2011, Pages 22-29

  Gaitán, María I ^a   Shea, Colin D ^a   Evangelou, Iordanis E ^a   Stone, Roger D ^a   Fenton, Kaylan M ^a   Bielekova, Bibiana ^a   Massacesi, Luca ^a,b   Reich, Daniel S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; FLUID ATTENUATED INVERSION RECOVERY; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; RING OPENING; TISSUE REPAIR;

ADULT; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; YOUNG ADULT;

EID: 79960839634     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22472     Document Type: Article

References (40)

1. Charcot JM,. Histologie de la sclérose en plaques. Gaz des HÃp (Paris) 1868; 41: 554-566.
2. Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 1039-1042. (Pubitemid 30390539)
3. Adams CW,. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci 1975; 25: 165-182.
4. Barnett MH, Prineas JW,. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004; 55: 458-468. (Pubitemid 38391962)
5. Henderson AP, Barnett MH, Parratt JD, Prineas JW,. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 2009; 66: 739-753.
6. Bruck W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-793. (Pubitemid 27481551)
7. Grossman RI, Braffman BH, Brorson JR, et al. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988; 169: 117-122.
8. Lassmann H,. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am 2008; 18: 563-576, ix.
9. Katz D, Taubenberger J, Raine C, et al. Gadolinium-enhancing lesions on magnetic-resonance-imaging: neuropathological findings. Ann Neurol 1990; 28: 243.
10. Alvarez JI, Cayrol R, Prat A,. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta 2011; 1812: 252-264.
11. Mahad DJ, Lawry J, Howell SJL, Woodroofe MN,. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse. Mult Scler 2003; 9: 189-198. (Pubitemid 36426993)
12. Holman DW, Klein RS, Ransohoff RM,. The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 2011; 1812: 220-230.
13. Stolp HB, Dziegielewska KM,. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 2009; 35: 132-146.
14. Capra R, Marciano N, Vignolo LA, et al. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. Arch Neurol 1992; 49: 687-689.
15. Morgen K, Jeffries NO, Stone R, et al. Ring-enchancement in multiple sclerosis: marker of disease severity. Mult Scler 2001; 7: 167-171. (Pubitemid 32651816)
16. Davis M, Auh S, Riva M, et al. Ring and nodular multiple sclerosis lesions: a retrospective natural history study. Neurology 2010; 74: 851-856.
17. He J, Grossman RI, Ge Y, Mannon LJ,. Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol 2001; 22: 664-669. (Pubitemid 32318693)
18. Masdeu JC, Quinto C, Olivera C, et al. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000; 54: 1427-1433. (Pubitemid 30210460)
19. Bagheri MH, Meshksar A, Nabavizadeh SA, et al. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis. Acad Radiol 2008; 15: 15-23. (Pubitemid 350217020)
20. Lovblad KO, Anzalone N, Dorfler A, et al. MR imaging in multiple sclerosis: review and recommendations for current practice. AJNR Am J Neuroradiol 2010; 31: 983-989.
21. Filippi M,. Enhanced magnetic resonance imaging in multiple sclerosis. Mult Scler 2000; 6: 320-326.
22. Nessler S, Boretius S, Stadelmann C, et al. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. Brain 2007; 130: 2186-2198. (Pubitemid 47236612)
23. Tofts PS, Kermode AG,. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17: 357-367.
24. Larsson HBW, Stubgaard M, Frederiksen JL, et al. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990; 16: 117-131. (Pubitemid 20353802)
25. Kermode AG, Tofts PS, Thompson AJ, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40: 229-235. (Pubitemid 20099429)
26. Kurtzke JF,. A new scale for evaluating disability in multiple sclerosis. Neurology 1955; 5: 580-583.
27. Hawkins CP, Munro PM, MacKenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain. 1990; 113 (Pt 2): 365-378. (Pubitemid 20136147)
28. McDonald WI, Miller DH, Barnes D,. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18: 319-334.
29. Fazekas F, Soelberg-Sorensen P, Comi G, Filippi M,. MRI to monitor treatment efficacy in multiple sclerosis. J Neuroimaging 2007; 17 (suppl 1): 50S-55S. (Pubitemid 46558270)
30. Daumer M, Neuhaus A, Morrissey S, et al. MRI as an outcome in multiple sclerosis clinical trials. Neurology 2009; 72: 705-711.
31. Hochmeister S, Grundtner R, Bauer J, et al. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 2006; 65: 855-865. (Pubitemid 44371231)
32. Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004; 127 (pt 1): 111-119. (Pubitemid 38055350)
33. Napoli I, Neumann H,. Protective effects of microglia in multiple sclerosis. Exp Neurol 2010; 225: 24-28.
34. Barilaro A, Zellini F, Caleri F, et al. Kinetic of brain MRI gadolinium enhancing lesions in multiple sclerosis. Eur J Neurol 2004; 11: 20.
35. van Horssen J, Brink BP, de Vries HE, et al. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007; 66: 321-328. (Pubitemid 46559025)
36. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400. (Pubitemid 32848742)
37. Werring DJ, Brassat D, Droogan AG, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000; 123 (pt 8): 1667-1676. (Pubitemid 30481190)
38. Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43: 809-814. (Pubitemid 28280225)
39. Ludemann L, Warmuth C, Plotkin M, et al. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol 2009; 70: 465-474.
40. Lacerda S, Law M,. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009; 19: 527-557.